City of Industry, CA -- (SBWire) -- 06/26/2018 --This report studies the global Parkinson's Disease market status and forecast, categorizes the global Parkinson's Disease market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
The global Parkinson's Disease market is valued at 4240 million US$ in 2017 and will reach 6810 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2018-2025.
Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/523940/global-parkinson-s-disease-sales-market
The major players covered in this report
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Valeant Pharmaceuticals
Acadia
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics
Click to view the full report TOC, figure and tables: https://www.qyresearch.com/index/detail/523940/global-parkinson-s-disease-sales-market
Global Parkinson's Disease Sales Market Share, Trend, Segmentation and Forecast to 2025
Global Parkinson's Disease Sales Market report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency.